Comparative efficacy and tolerability between 0.1% mometasone furoate cream and 1% hydrocortisone cream for corticoid sensitive treatment in pediatry;Estudo comparativo entre furoato de mometasona a 0,1% e hidrocortisona a 1% nas dermatoses corticossensiveis em criancas

Anais Brasileiros de Dermatologia

Volumn 74, Issue 4, 1999, Pages 351-355

  Alonso, Fausto F ^a   Pessoa Mendes, Adriana ^a   Costa Soares De Sá, Bianca ^a   Nappo, Vanessa ^b  

^a Dermatologia ^*

^b Sigma Pharma   (Brazil)

Author keywords

Comparative trial; Dermatitis; Hidrocortisone; Mometasone furoate

Indexed keywords

CORTICOSTEROID; HYDROCORTISONE; MOMETASONE FUROATE;

ADOLESCENT; ARTICLE; ATOPIC DERMATITIS; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTACT DERMATITIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DRUG EFFICACY; DRUG POTENCY; DRUG TOLERANCE; ECZEMA; FEMALE; HUMAN; MALE; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SEBORRHEIC DERMATITIS; SKIN DISEASE; STATISTICAL ANALYSIS; TOPICAL DRUG ADMINISTRATION;

EID: 6544229188     PISSN: 03650596     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Sulzberg ME, Witten VH. Preliminary and short reports. The effect of topically applied compound F in selected dermatosis. J Invest Dermatol 1952;19:101-2.
2. Rajka G, Avrach W. Gärtner L. Overgaard-Petersen EH. Mometasone furoate ointment 0.1% once daily versus betamethasone valerate cream 0.1% twice daily in the treatment of patients with contact or atopic allergic dermatitis. Curr Ther Res 1993;54(1):23-30.
3. Katz HI, Prawer SE, Watson MJ et al. Mometasone furoate ointment 0.1% vs hydrocortisone ointment 1% in psoriasis. Int J Dermatol 1989;28:342-4.
4. Cornell RC, Stoughton RB. The use of topical steroids in psoriasis. Dermatol Clin 1984;2:397-409.
5. Rosenthal D. Duke E. A clinical investigation of the efficacy and safety of mometasone furoate ointment 0.1% vs betamethasone valerate ointment 0.1% in the treatment of psoriasis. Curr Ther Res 1988;44:790-801.
6. Medansky RS, Bressink R. Cole GW et al. Mometasone furoate ointment and cream 0.1% in the treatment of psoriasis; comparison with ointment and cream formulations of fluocinolone acetonide 0.025% and triamcinolone acetonide 0.1%. Cutis 1988;42:480-5.
7. Medansky RS, Brody NI, Kanof NB et al. Clinical investigations of mometasone furoate - a novel nonfluorinated topical corticosteroid. Semin Dermatol 1987;6:94-100.
8. Bressink R, Williams J. Peels E. Comparison of the effect of mometasone furoate ointment 0.1% and hydrocortisone ointment 1.0% on adrenocortical function in psoriasis patients. Today's Ther Trends 1988;5:25-35.
9. Hoybye S. Moller SB, Bang FC et al. Continuous and intermitent treatment of atopic dermatitis in adults with mometasone furoate versus hydrocortisone 17-butyrate. Curr Ther Res 1991;50:67-72.
10. Vernon HJ, Lane AT, Weston W. Comparison of mometasone furoate 0.1% cream and hydrocortisone 1.0% cream in the treatment of childhood atopic dermatitis. J Am Acad Dermatol 1991;24:603-7.
11. Viglioglia P, Jones ML, Pects EA. Once-daily 0 1% mometasone furoate cream versus twice-daily 0.1% betamethasone valerate cream in the treatment of a variety of dermatoses. J Int Med Res 1990;18:460-7.
12. Vickers CFH. Existence of reservoir in the stratum corneum. Arch Dermatol 1963;88:72-5.
13. Barton RE, Jakway JR, Smith SR, Siegel, MIS. Citokine inhibition by a novel steroid, mometasone furoate. Immunopharmacology and immunotoxicology 1991;13(3):251-61.